Charges are being laid against Gary Tanner, a former executive at Valeant Pharmaceuticals International Inc. and Andrew Davenport, the former CEO of Philidor Rx Services.
The "fraudulent scheme" allegedly cost investors billions of dollars.
"We have a very ethical company and we're very confident in terms of the future."
Quebec's securities regulator says it hasn't launched a formal investigation into Valeant, which has its headquarters in Laval near Montreal, but is watching the situation "very seriously.''
It looks like we could soon be adding another to the growing list of great Canadian corporate flame-outs. There was Nortel
NEW YORK - Valeant Pharmaceuticals International Inc. says that federal prosecutors are seeking information on the drug developer's
Congressional Democrats are pressing a Republican committee chairman to force a pharmaceutical company to turn over documents